Comparative evaluation of immunogenicity of monovalent type 1 oral poliovirus vaccine (mOPV1) versus trivalent OPV (tOPV): a randomized double-blind trial set in India (Panacea Biotech Ltd mOPV1 study).
Latest Information Update: 03 Mar 2023
At a glance
- Drugs Poliovirus vaccine live oral (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Panacea Biotec
- 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 02 Jun 2011 Primary endpoint 'Seroconversion-rate' has been met.
- 02 Jun 2011 Results published in Vaccine.